Galus, W.; Kaczmarczyk, A.; Walawska-Hrycek, A.; Siuda, J.; Polewka, M.; Lasek-Bal, A.; Puz, P.
Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers. Medicina 2025, 61, 1568.
https://doi.org/10.3390/medicina61091568
AMA Style
Galus W, Kaczmarczyk A, Walawska-Hrycek A, Siuda J, Polewka M, Lasek-Bal A, Puz P.
Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers. Medicina. 2025; 61(9):1568.
https://doi.org/10.3390/medicina61091568
Chicago/Turabian Style
Galus, Weronika, Aleksandra Kaczmarczyk, Anna Walawska-Hrycek, Joanna Siuda, Milena Polewka, Anetta Lasek-Bal, and Przemysław Puz.
2025. "Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers" Medicina 61, no. 9: 1568.
https://doi.org/10.3390/medicina61091568
APA Style
Galus, W., Kaczmarczyk, A., Walawska-Hrycek, A., Siuda, J., Polewka, M., Lasek-Bal, A., & Puz, P.
(2025). Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers. Medicina, 61(9), 1568.
https://doi.org/10.3390/medicina61091568
